2Haruhiko Taguchi, Motomichi Takahashi, Hiroyuki Yamaguchi, et al. Exprimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6[J]. J. Med. Microbiol. Vol. 51(2002), 336-343.
3Yuji Aiba, Hiroki Ishikawa, Keiko Shimizu, et al. Role of Internalization in the Pathogenicity of Shiga Toxin-Producing Escherichia coli Infection In a Gnotobiotic Murine Model[J]. Microbiol. Immunol. 46(11). 723-731, 2002.
4Kenji Funatogawa, Takayuki Ide, Fumiko Kirikae, et al. Use of Immunoglobulin Enriched Bovine Colostrum against Oral Challenge with enterrohaemorrhagic Escherichia coli O157:H7 in Mice[J]. Microbilo. Immunol. 46(11), 761-766, 2002.
5Gaylen A. Uhlich, James E. Keen, and Roert O. Eldert, Variations in the csgD Promoter of Escherichia coli O157:H7 Associated with Increased Virulence in Mice and Increased Invasion of HEp-2 Cells[J]. Infection and Immunity. Jan. 2002, 395-399.
6Wadolkowski,E.A., J.A.Burris, and A.D.O'Brien. 1990 Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7[J]. Infect. Immun. 58:2438-2445.
7Takaaki Kurioka, Yoshihisa Yunou, and Eiji Kita, Enhancement of Susceptibility to Shiga Toxin-Producing Escherichia coli O157:H7 by Protein Calorie Malnutrition in Mice, Infection and Immunity. Dec. 1990. 3959-3965.
3[1]Tarr P I.Escherichia coli O157:H7:clinical,diagnostic and epidemiological aspects of human intection. Clin Infect Dis,1995,20:1-10.
4[2]Wadolkowski E A, Burris J A, O' Brien A D. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157: H7. Infect Immun, 1990, 58 ( 8 ):2438-2445.
5[5]Isogai E,Isogai H,Hayashi S,et al.Effect of antibiotics,1evofloxacin and fosfomycin on a mouse model with Escherichia coli O157 infection.Microbiol Immunol,2000,44(2):89-95.
6[7]Fujii J, Kita T, Yoshida S, et al. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H7 in mitomycin-treated mice. Infect Immun, 1994,62 ( 8 ): 3447-3453.
7[8]Moake J L. Haemolytic-uraemic syndrome: basic science.Lancet, 1994,343:393-397.
8[9]Louise C B, Obrig T G. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin Ⅱ with human renal endothelial cells. J Infect Dis 1995,172: 1397- 1401.
9[10]Cimolai N S, Basalyga D G Mah B J, et al. A continuing assessment of risk factors for the development of Escherichia coli O157: H7-associated hemolytic uremic syndrome. Clin Nephrol, 1994,42: 85-89.
